AU2001237379A1 - Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction - Google Patents

Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction

Info

Publication number: AU2001237379A1
Authority: AU; Australia
Prior art keywords: benzothieno; pde; pyrimidines; treatment; inhibitory effect
Prior art date: 2000-03-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001237379A

Other versions

AU2001237379B2 (en

Inventor

Marian Brandle

Thomas Ehring

Claudia Wilm

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Patent GmbH

Original Assignee

Merck Patent GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-03

Filing date

2001-02-13

Publication date

2001-11-22

2000-03-03 Priority claimed from DE10010612A external-priority patent/DE10010612A1/en

2001-02-13 Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH

2001-11-22 Publication of AU2001237379A1 publication Critical patent/AU2001237379A1/en

2005-05-05 Application granted granted Critical

2005-05-05 Publication of AU2001237379B2 publication Critical patent/AU2001237379B2/en

2021-02-13 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10010612.9		2000-03-03
DE10010612A DE10010612A1 (en)	2000-03-03	2000-03-03	Treatment of erectile dysfunction without inducing circulatory side-effects, using penis-specific phosphodiesterase V inhibitors, preferably benzo (4,5) thieno (2,3-d) pyrimidine derivatives
PCT/EP2001/001557 WO2001064192A2 (en)	2000-03-03	2001-02-13	Use of benzothieno-2,3-d-pyrimidines with pde v inhibitory effect for the treatment of erectile dysfunction

Publications (2)

Publication Number	Publication Date
AU2001237379A1 true AU2001237379A1 (en)	2001-11-22
AU2001237379B2 AU2001237379B2 (en)	2005-05-05

Family

ID=7633516

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2001237379A Ceased AU2001237379B2 (en)	2000-03-03	2001-02-13	Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction
AU3737901A Pending AU3737901A (en)	2000-03-03	2001-02-13	Use of pde v inhibitors

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU3737901A Pending AU3737901A (en)	2000-03-03	2001-02-13	Use of pde v inhibitors

Country Status (13)

Country	Link
US (1)	US20030022906A1 (en)
EP (1)	EP1259229B1 (en)
JP (1)	JP2004504269A (en)
AT (1)	ATE297719T1 (en)
AU (2)	AU2001237379B2 (en)
CA (1)	CA2401585A1 (en)
CO (1)	CO5210873A1 (en)
DE (2)	DE10010612A1 (en)
ES (1)	ES2241798T3 (en)
MX (1)	MXPA02008571A (en)
PE (1)	PE20011165A1 (en)
PT (1)	PT1259229E (en)
WO (1)	WO2001064192A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10031585A1 (en) *	2000-06-29	2002-01-10	Merck Patent Gmbh	2-aminoalkyl-thieno [2,3-d] pyrimidine
WO2003035653A1 (en) *	2001-10-26	2003-05-01	Nippon Soda Co.,Ltd.	Pyridothienopyrimidine compound and salt thereof
US20050042177A1 (en) *	2003-07-23	2005-02-24	Elan Pharma International Ltd.	Novel compositions of sildenafil free base
CA2694009A1 (en) *	2007-07-26	2009-01-29	F. Hoffmann-La Roche Ag	Dual modulators of 5-ht2a and d3 receptors
CN104945412B (en) *	2015-05-26	2018-01-23	温州医科大学	Tetrahydro benzo thieno [2,3 d] aminopyridine derivative for FGFR1 and preparation method and application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1309561A (en) *	1997-05-29	2001-08-22	持田制药株式会社	Therapeutic agent for erection failure
US6037346A (en) *	1997-10-28	2000-03-14	Vivus, Inc.	Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
DE19819023A1 (en) *	1998-04-29	1999-11-04	Merck Patent Gmbh	Thienopyrimidines
US6265420B1 (en) *	1998-06-23	2001-07-24	Medinox, Inc.	Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide
AU1028000A (en) *	1998-08-25	2000-03-14	Alpharma-Isis Gmbh And Co. Kg	Medicament utilization and combination
ES2187234A1 (en) *	1999-04-30	2003-05-16	Lilly Icos Llc	ORAL DOSAGE FORM TO TREAT SEXUAL DYSFUNCTION.
DE19928146A1 (en) *	1999-06-19	2000-12-21	Merck Patent Gmbh	New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence
US6476037B1 (en) *	2000-03-23	2002-11-05	The Regents Of The University Of California	L-arginine and phosphodiesterase (PDE) inhibitor synergism

2000
- 2000-03-03 DE DE10010612A patent/DE10010612A1/en not_active Withdrawn
2001
- 2001-02-13 MX MXPA02008571A patent/MXPA02008571A/en unknown
- 2001-02-13 ES ES01909743T patent/ES2241798T3/en not_active Expired - Lifetime
- 2001-02-13 WO PCT/EP2001/001557 patent/WO2001064192A2/en not_active Ceased
- 2001-02-13 JP JP2001563089A patent/JP2004504269A/en active Pending
- 2001-02-13 AU AU2001237379A patent/AU2001237379B2/en not_active Ceased
- 2001-02-13 AT AT01909743T patent/ATE297719T1/en not_active IP Right Cessation
- 2001-02-13 US US10/220,416 patent/US20030022906A1/en not_active Abandoned
- 2001-02-13 AU AU3737901A patent/AU3737901A/en active Pending
- 2001-02-13 PT PT01909743T patent/PT1259229E/en unknown
- 2001-02-13 CA CA002401585A patent/CA2401585A1/en not_active Abandoned
- 2001-02-13 EP EP01909743A patent/EP1259229B1/en not_active Expired - Lifetime
- 2001-02-13 DE DE50106519T patent/DE50106519D1/en not_active Expired - Fee Related
- 2001-03-01 PE PE2001000209A patent/PE20011165A1/en not_active Application Discontinuation
- 2001-03-02 CO CO01016924A patent/CO5210873A1/en unknown

Similar Documents

Publication	Publication Date	Title
NO20024364D0 (en)	2002-09-12	Use of pyrido [3,2-E] pyrazinones as inhibitors of phosphodiesterase 5 for the treatment of erectile dysfunction
AU4583899A (en)	2000-01-10	Nasal administration of sildenafil for the treatment of erectile dysfunction
PL343794A1 (en)	2001-09-10	Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
IL222455A0 (en)	2012-12-02	Methods for the preparation, isolation and purification of epothilone b
AU2001250821A1 (en)	2001-09-24	Methods and compositions for the treatment and prevention of erectile dysfunction
AU2002238106A1 (en)	2002-08-28	Melanocortin metallopeptides for treatment of sexual dysfunction
AU2003219981A1 (en)	2003-09-22	Benzimidazole-derivatives for the treatment of sexual dysfunction
AU2001274649A1 (en)	2002-01-02	Topical preparation of alprostadil for the treatment of erectile dysfunction
IL162154A0 (en)	2005-11-20	Prostagandin composition for the treatment of erectile dysfunction
ZA200501288B (en)	2005-09-05	Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2002246924A1 (en)	2002-07-16	Treatment of erectile dysfunction with rho-kinase inhibitors
AU2003291886A1 (en)	2004-06-30	Thiophenederivatives for the treatment of flavivirus infections
AU2001237379A1 (en)	2001-11-22	Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction
AU7652400A (en)	2001-04-17	Novel combination for the treatment of sexual dysfunction
AU2001284125A1 (en)	2002-02-18	Medicine for fighting against sexual dysfunction
ZA200203069B (en)	2002-11-27	Peptides for treatment of erectile dysfunction.
AU2000275972A1 (en)	2002-03-22	Pde iii inhibitors for treating sexual dysfunction
AU2001250530A1 (en)	2001-11-12	Treatment of conditions of the central nervous system using mycobacteria
ZA200205415B (en)	2003-10-13	Novel therapeutic use of enoxaparin.
AU2003231154A1 (en)	2003-11-10	Topical treatment of erectile dysfunction
ZA992793B (en)	2000-10-19	Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction.
DK1259229T3 (en)	2005-09-05	Use of benzoothieno [2,3-d] pyrimidines with PDE V inhibitory effect in the treatment of erectile dysfunction
HK1066735A (en)	2005-04-01	Prostaglandin composition for the treatment of erectile dysfunction
HK1072934A (en)	2005-09-16	Benzimidazole-derivatives for the treatment of sexual dysfunction
AU2002219247A1 (en)	2002-06-24	Use of levosimendan for treating erictile dysfunction